Athira Pharma Inc

General ticker "ATHA" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $23.5M

Athira Pharma Inc does not follow the US Stock Market performance with the rate: -28.2%.

Estimated limits based on current volatility of 4.3%: low 0.52$, high 0.56$

Factors to consider:

  • Current price 60.5% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.30$, 3.13$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.51$, 3.40$]

Financial Metrics affecting the ATHA estimates:

  • Negative: Non-GAAP EPS, $ of -3.09 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -57.91 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39

Similar symbols

Short-term ATHA quotes

Long-term ATHA plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $64.02MM $104.02MM $125.47MM
Operating Income $-64.02MM $-104.02MM $-125.47MM
Non-Operating Income $8.84MM $5.16MM $7.79MM
Interest Expense $0.00MM $24.32MM $0.00MM
R&D Expense $42.79MM $61.46MM $93.79MM
Income(Loss) $-55.19MM $-98.86MM $-117.67MM
Profit(Loss) $-55.19MM $-98.86MM $-117.67MM
Stockholders Equity $321.08MM $235.14MM $130.19MM
Inventory $2.34MM $1.23MM $0.00MM
Assets $332.01MM $258.15MM $160.25MM
Operating Cash Flow $-43.10MM $-72.47MM $-100.75MM
Capital expenditure $1.57MM $1.14MM $0.30MM
Investing Cash Flow $-4.08MM $57.66MM $95.09MM
Financing Cash Flow $97.09MM $0.65MM $0.49MM
Earnings Per Share* $-1.47 $-2.31 $-3.10

* EPS are Split Adjusted, recent splits may be reflected with a delay.